Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome.

Ashtari, Fereshteh; Soltani, Rasool; Shokouhi, Shervin; Rismanbaf, Ali; Hajiahmadi, Somayeh; Hakamifard, Atousa.

Afiliação

Ashtari F; Isfahan Neuroscience Research Center Isfahan University of Medical Sciences Isfahan Iran.
Soltani R; Department of Clinical Pharmacy and Pharmacy Practice School of Pharmacy and Pharmaceutical Sciences Isfahan University of Medical Sciences Isfahan Iran.
Shokouhi S; Department of Infectious Diseases and Tropical Medicine Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran.
Rismanbaf A; Infectious Diseases and Tropical Medicine Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
Hajiahmadi S; Department of Clinical Pharmacy and Pharmacy Practice School of Pharmacy and Pharmaceutical Sciences Isfahan University of Medical Sciences Isfahan Iran.
Hakamifard A; Department of Radiology School of Medicine Isfahan University of Medical Sciences Isfahan Iran.

Clin Case Rep ; 9(7): e04468, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34295489

ABSTRACT

Methylprednisolone pulse therapy has significant anti-inflammatory effects in multiple sclerosis. Acute respiratory distress syndrome as a probable adverse effect of methylprednisolone pulse therapy in MS patients should be considered.

Palavras-chave

ARDS; acute respiratory distress syndrome; methylprednisolone; multiple sclerosis